Pituitary metastasis from renal cell carcinoma is rare and has never been reported for renal cell carcinoma primarily treated with sorafenib. Herein, we present a case of an advanced clear. cell renal cell carcinoma in which pituitary metastasis progressed but extracerebral metastases showed partial response to sorafenib treatment.
语种：
外文
被引次数：
WOS：
PubmedID：
第一作者：
第一作者单位：[1]Huazhong Sci & Technol Univ, Tongji Med Coll, Tongji Hosp, Ctr Oncol, Wuhan 430030, Hubei, Peoples R China
通讯作者：
通讯机构：[1]Huazhong Sci & Technol Univ, Tongji Med Coll, Tongji Hosp, Ctr Oncol, Wuhan 430030, Hubei, Peoples R China[*1]Huazhong Sci & Technol Univ, Tongji Med Coll, Tongji Hosp, Ctr Oncol, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Yang Lin,Yu Shi-Ying,Hu Guang-Yuan.Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment[J].CHINESE JOURNAL OF CANCER.2013,32(6):353-356.doi:10.5732/cjc.012.10184.
APA：
Yang, Lin,Yu, Shi-Ying&Hu, Guang-Yuan.(2013).Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment.CHINESE JOURNAL OF CANCER,32,(6)
MLA：
Yang, Lin,et al."Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment".CHINESE JOURNAL OF CANCER 32..6(2013):353-356
